Gastroparesis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

What is gastroparesis and how can it be treated? - Philly.com



Philly.com
 
What is gastroparesis and how can it be treated? 
Philly.com
Remember those patients suffering with gastroparesis? The young female, after following the gastroparesis diet for six months, says she feels like a new person. She is now able to eat fresh fruits and vegetables and enjoy salads. She can now go out to ...

 


Diabetic Gastroparesis Market Analysis by Key players, Application & Future Demand ? Pipeline Review, H1 2018 - Facts of Week



ExpressObserver
 
Diabetic Gastroparesis Market Analysis by Key players, Application & Future Demand ? Pipeline Review, H1 2018 
Facts of Week
Diabetic Gastroparesis Pharmaceutical and Healthcare latest pipeline provides comprehensive information on the therapeutics under development for Diabetic Gastroparesis .The study covers complete descriptive pharmacological action of the therapeutics ...
Global Diabetic Gastroparesis Treatment Market 2018 ... ExpressObserver

all 3 news articles » 


Diabetic Gastroparesis Pipeline Research Report 2018 - Version of Event



Diabetic Gastroparesis Pipeline Research Report 2018 
Version of Event
Diabetic Gastroparesis- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding ...

and more » 


Diabetic Gastroparesis Treatment Market Driving Factors, Market Analysis, Investment Feasibility and Trends 2022 - The Financial



Diabetic Gastroparesis Treatment Market Driving Factors, Market Analysis, Investment Feasibility and Trends 2022 
The Financial
Diabetic Gastroparesis Treatment Market report provides comprehensive analysis for those who are looking for Business expand in various regions, manufacturers, New entrants in the industry, Professional services/solutions providers, Government bodies ...

 


2021 Gastroparesis Drugs Market: Technological Innovation, Opportunities, Regions, Manufacturers & Forecast - Facts of Week



2021 Gastroparesis Drugs Market: Technological Innovation, Opportunities, Regions, Manufacturers & Forecast 
Facts of Week
The ?Gastroparesis Drugs Market? report gives an intelligible understanding of the present market condition which includes of substantial and predictable upcoming keyword opportunities for the investors and new entrants. This Report provides key ...

and more » 


Gastroparesis Market with Analysis, Scope, Share, Forecast and ... - The Financial



Gastroparesis Market with Analysis, Scope, Share, Forecast and ... 
The Financial
?Gastroparesis Market Report offers detailed analysis of the market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Gastroparesis market ...

and more » 


A Look at Vanda Pharmaceuticals' Product Portfolio - Market Realist



Market Realist
 
A Look at Vanda Pharmaceuticals' Product Portfolio 
Market Realist
Vanda Pharmaceuticals licensed tradipitant from Eli Lilly (LLY) in April 2012. Tradipitant is in clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis. In 3Q17, Vanda Pharmaceuticals completed a placebo ...
Armistice Capital Llc Increased Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Stake by $17.19 Million BZ Weekly
Vanda Pharmaceuticals Inc. (VNDA)'s Trend Up, Especially After Today's Strong Session Frisco Fastball
Financial Newsletter - Zacks Zacks
Zacks 
all 49 news articles » 


Gastroparesis Drugs Market Projected to Reach $6,486 Million at a ... - Chicago Evening Post



Gastroparesis Drugs Market Projected to Reach $6,486 Million at a ... 
Chicago Evening Post
Portland, OR ? 02/16/2018 ? The global gastroparesis market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis is a medical condition of the stomach, which affects the ...

and more » 


Evoke Announces Discovery of Sex-Based Pharmacokinetic ... - GlobeNewswire (press release)



GlobeNewswire (press release)
 
Evoke Announces Discovery of Sex-Based Pharmacokinetic ... 
GlobeNewswire (press release)
SOLANA BEACH, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced additional findings from its comparative exposure ...

and more » 


Evoke Pharma Schedules Conference Call and Webcast for Fourth ... - Nasdaq



The Lincolnian Online
 
Evoke Pharma Schedules Conference Call and Webcast for Fourth ... 
Nasdaq
SOLANA BEACH, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the Company will release financial results for the ...
Analysts Set Evoke Pharma Inc (EVOK) Target Price at $9.14 - The ... The Lincolnian Online

all 6 news articles »